Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Has CME:

Do I Have Access?

Access:

Availability:

Participation Type:

Categories:

Browse by: Sort by:
<< first | < prev page: of 8 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 presentations: 1 to 25 of 183
Linking Lipid Metabolism to Cardiometabolic Disease
Adipose Tissue Plasticity and Cardiometabolic Risk
Michael Dennis Jensen, MD
Mayo Clinic, Rochester, MN
from ENDO 2017 on April 1, 2017 9:45 AM-11:15 AM
Linking Lipid Metabolism to Cardiometabolic Disease
Fat Catabolism in Cardiometabolic Disease: Friend or Foe?
Erin E Kershaw, MD
University of Pittsburgh, Pittsburgh, PA
from ENDO 2017 on April 1, 2017 9:45 AM-11:15 AM
Linking Lipid Metabolism to Cardiometabolic Disease
Adipose Tissue Dynamics in Metabolism
Steven R Smith, MD
Florida Hospital, Orlando, FL
from ENDO 2017 on April 1, 2017 9:45 AM-11:15 AM
Lipodystrophy Syndromes
Lipodystrophy Syndromes
Abhimanyu Garg, MD
University of Texas SW Medical Center, Dallas, TX
from ENDO 2017 on April 1, 2017 2:30 PM-3:15 PM
Recent Developments in Diabetic Kidney Disease
Glomerular Lipids and the Kidney
Alessia Fornoni, MD, PhD
University of Miami, Miami, FL
from ENDO 2017 on April 1, 2017 4:30 PM-6:00 PM
Recent Developments in Diabetic Kidney Disease
Novel Treatment Targets for Diabetic Kidney Disease
Robert C Stanton, MD
Joslin Diabetes Center, Boston, MA
from ENDO 2017 on April 1, 2017 4:30 PM-6:00 PM
The Consequences of Ectopic Fat Deposition in the Liver
The Metabolic Effects of Dysfunctional Fatty Acid Metabolism in Obesity
Amalia Gastaldelli, PHD
CNR, Inst of Clinical Physiology, Pisa, Italy
from ENDO 2017 on April 1, 2017 4:30 PM-6:00 PM
The Consequences of Ectopic Fat Deposition in the Liver
Heterogeneity of NAFLD - Implications for the Clinic
Hannele Yki-Jarvinen, MD FRCP
University of Helsinki, Helsinki, Finland
from ENDO 2017 on April 1, 2017 4:30 PM-6:00 PM
The Consequences of Ectopic Fat Deposition in the Liver
Imaging-Based Non-Invasive Diagnosis of NASH
Richard L. Ehman, MD
Mayo Clinic, Rochester, MN
from ENDO 2017 on April 1, 2017 4:30 PM-6:00 PM
Lipid Disorders in Women
Lipid Disorders in Women
Lisa R. Tannock, MD
University of Kentucky, Lexington, KY
from ENDO 2017 on April 2, 2017 9:45 AM-10:30 AM
The Utilization of Cholesterol Guidelines and Recommendations in Managing Patients with Dyslipidemia
The Utilization of Cholesterol Guidelines and Recommendations in Managing Patients with Dyslipidemia
James A Underberg, MD
NYU Langone Medical Center, New York, NY
from ENDO 2017 on April 2, 2017 10:45 AM-11:30 AM
Appropriate Use of PCSK9 Monoclonal Antibodies
Appropriate Use of PCSK9 Monoclonal Antibodies
Anne Carol Goldberg, MD
Washington University, Saint Louis, MO
from ENDO 2017 on April 3, 2017 2:30 PM-3:15 PM
Targeting Triglycerides: A Novel Means for Cardiovascular Disease Prevention
Angiopoietin-like Proteins As Mediators of Circulating Triglycerides and Targets for CV Risk Reduction
Kiran Musunuru, MD, PhD, MPH
University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
from ENDO 2017 on April 4, 2017 11:45 AM-1:15 PM
Targeting Triglycerides: A Novel Means for Cardiovascular Disease Prevention
Control of Serum Triglycerides By ApoC3
Anne Carol Goldberg, MD
Washington University, Saint Louis, MO
from ENDO 2017 on April 4, 2017 11:45 AM-1:15 PM
Targeting Triglycerides: A Novel Means for Cardiovascular Disease Prevention
Novel Therapeutics in Hypertriglyceridemia
Steve Gryn, MD
Western University, London, ON
from ENDO 2017 on April 4, 2017 11:45 AM-1:15 PM
The Emerging Role of FGF23 in Health
FGF23: Revealing Novel Control Points for Phosphate Metabolism
Kenneth E. White, PHD
Indiana Univ Schl of Med, Indianapolis, IN
from ENDO 2017 on April 4, 2017 11:45 AM-1:15 PM
The Emerging Role of FGF23 in Health
Role of FGF23 in CKD Anemia
Despina Sitara, Ph.D.
New York University College of Dentistry, New York, NY
from ENDO 2017 on April 4, 2017 11:45 AM-1:15 PM
The Emerging Role of FGF23 in Health
Cardiovascular Complications in CKD: Role of the FGF23/Klotho/Phosphate Axis
Cecilia Giachelli, PhD
University of Washington, Seattle, WA
from ENDO 2017 on April 4, 2017 11:45 AM-1:15 PM
The Statin Intolerant Patient
The Statin Intolerant Patient
Robert Harold Eckel, MD
University of Colorado Anchutz Medical Campus, Aurora, CO
from Diabetes Diagnosis & Management 2017 on March 31, 2017 12:45 PM-1:30 PM
Centennial ESAP, Part 1
Centennial ESAP, Part 1
Alan C. Dalkin, MD
University of Virginia, Charlottesville, VA
from Clinical Endocrinology Update 2016 on September 8, 2016 1:15 PM-2:00 PM
Sexual Function and Dysfunction in Reproductive Aged Women
Sexual Function and Dysfunction in Reproductive Aged Women
Sarah L. Berga, MD
Wake Forest Baptist Medical Center, Winston Salem, NC
from Clinical Endocrinology Update 2016 on September 8, 2016 2:15 PM-2:45 PM
Statin Safety and Tolerability
Statin Safety and Tolerability
Connie B. Newman, MD
New York University, Warren, NJ
from Clinical Endocrinology Update 2016 on September 9, 2016 11:00 AM-11:35 AM
Pros and Cons of the Lipid Guidelines
Pros and Cons of the Lipid Guidelines
Alan Chait, MD
University of Washington, Seattle, WA
from Clinical Endocrinology Update 2016 on September 9, 2016 11:35 AM-12:00 PM
Q&A/Panel Discussion with Drs. Buchanan, Bessesen, Newman, and Chait
Q&A/Panel Discussion with Drs. Buchanan, Bessesen, Newman, and Chait
Daniel H. Bessesen, MD
University of Colorado School of Medicine, Aurora, CO
Connie B. Newman, MD
New York University, Warren, NJ
Alan Chait, MD
University of Washington, Seattle, WA
from Clinical Endocrinology Update 2016 on September 9, 2016 12:00 PM-12:15 PM
Statins and PCSK9 Monoclonal Antibodies
Statins and PCSK9 Monoclonal Antibodies
Anne C. Goldberg, MD
Washington University, Saint Louis, MO
from Clinical Endocrinology Update 2016 on September 9, 2016 1:30 PM-2:15 PM
<< first | < prev page: of 8 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 presentations: 1 to 25 of 183